Google
 

Archive for the ‘Endocrinology’ Category

Divigel(R) (estradiol Gel) 0.1 Percent Offers Lowest Approved Dose Of Estradiol For Treatment Of Moderate To Severe Hot Flashes

Thursday, May 15th, 2008

Medical specialists from around the country will gather this week to discuss the latest research in obstetrics and gynecology, and menopause and estrogen therapy will be among the information presented. "Estrogen therapy continues to be the gold standard for the management of hot flashes, the most common ...

Reducing The Severity Of Chronic Endocrine-Related Diseases: The Vitamin D Connection

Wednesday, April 9th, 2008

An adequate amount of Vitamin D is known to improve bone density, but the impact goes much further than bone strength; Vitamin D deficiency can impact nearly all of the body's functions. This topic will be investigated at the American Association of Clinical Endocrinologists (AACE) 17th Annual Meeting & Clinical ...

Majority Of Studies Of High-Fat Diets In Mice Inaccurately Portrayed

Wednesday, April 9th, 2008

Studies in mice provide the foundation for much of the belief that high-fat diets are detrimental to human health. However, the majority of studies on the health effects of high-fat diets in mice published in five respected scientific journals in 2007 were not ...

Heart Disease Predetermined By Oxygen Levels In The Womb

Wednesday, April 9th, 2008

The amount of oxygen available to a baby in the womb can affect their susceptibility to developing particular diseases later in life. Research presented at the annual Society for Endocrinology BES meeting in Harrogate shows that your risk of developing cardiovascular disease can be predetermined before birth, not only by ...

Adverse Effects Of Estrogen Replacement Therapy (ERT) Are Dose Related

Tuesday, April 8th, 2008

Recent clinical trials indicate that estrogen replacement therapy (ERT) may increase the risk of cardiovascular diseases. A new study in mice has examined whether adverse effects of ERT are related to the doses used. The study found that moderate and high doses of ERT increased problems in the kidney and ...

By Seeking Out Positive Experiences That Make Us Laugh We Can Do A Lot On Our Own To Stay Well

Tuesday, April 8th, 2008

In 2007 researchers investigating the interaction between the brain, behavior, and the immune system found that simply anticipating a mirthful laughter experience boosted health-protecting hormones. Now, two years later, the same researchers have found that the anticipation of a positive humorous laughter experience also reduces potentially detrimental stress hormones. According ...

Folkestone Seminar Explains How Choral Singing Boosts Health And Well Being, Folkestone, UK

Monday, April 7th, 2008

Choral singing has a profound and positive effect on health and well being, according to Dr Maria Sandgren, who will present her findings on Tuesday 29th April in Folkestone. Dr Sandgren's seminar, entitled 'Singing, Stress and the Endocrine System', is free of charge to the ...

Mitochondria Play Role In Pathogenesis Of Alzheimer’s Disease And Estrogen-Induced Neuroprotection

Monday, April 7th, 2008

As the major source of free radicals in cells, mitochondria contribute to the high levels of oxidative stress believed to play a role in the pathogenesis of Alzheimer's disease. Now, a new study from the laboratory of Dr. Roberta Brinton, University of Southern California, demonstrates that estrogen reduces this oxidative ...

Grandmother Hypothesis Of Menopause

Tuesday, April 1st, 2008

Insight into why females of some species undergo menopause while others do not has proven elusive despite an understanding of the biological mechanisms behind the change.However, new research by scientists at the Universities of Cambridge and Exeter suggests that menopause is an adaptation to minimize reproductive competition between generations of ...

Reduction In Sexual Satisfaction Is Not Associated With Cardiovascular Disease In Postmenopausal Women

Monday, March 31st, 2008

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) and collaborators nationwide have found that decreased sexual satisfaction in postmenopausal women, is not clearly associated with cardiovascular disease. This study appears in the April 2008 issue of The American Journal of Medicine.Female sexual dysfunction is a ...

Brain’s Smell Center Requires Growth Hormone To Set Up Brain’s Wiring

Saturday, March 29th, 2008

A human hormone known to stimulate the growth of cells throughout the body has a new role - helping to set up the proper nerve connections in the odor center of the brain, according to University of California, Berkeley, scientists.The hormone, insulin-like growth factor (IGF), is well-known to biomedical researchers ...

First Fully-Automated TSH Receptor Antibody Assay Launched By Roche Diagnostics

Friday, March 28th, 2008

Roche Diagnostics announced the launch of the first fully-automated immunoassay for the determination of autoantibodies to the thyroid stimulating hormone (TSH) receptor for the differential diagnosis of Graves' disease. The assay has been CE approved for use on the Elecsys / cobas e electrochemiluminescence immunoassay systems. Graves` disease, which ...

Brain’s Smell Center Requires Growth Hormone To Set Up Brain’s Wiring

Friday, March 28th, 2008

A human hormone known to stimulate the growth of cells throughout the body has a new role - helping to set up the proper nerve connections in the odor center of the brain, according to University of California, Berkeley, scientists.The hormone, insulin-like growth factor (IGF), is well-known to biomedical researchers ...

New Research Provides Genetic Clue To Parkinson’s Disease

Friday, March 28th, 2008

Researchers at Rhode Island Hospital and The Warren Alpert Medical School of Brown University have discovered a gene that could hold the key to developing new treatments for Parkinson's disease - a progressive and often debilitating movement disorder that affects as many as one million Americans.According to the findings of ...

TorreyPines Therapeutics Initiates Phase II Study Of Muscarinic Agonist NGX267 For Treatment Of Xerostomia

Friday, March 28th, 2008

TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced it has initiated a Phase II study of NGX267, a muscarinic agonist in development for xerostomia, or dry mouth, secondary to Sjogren's syndrome. The company is conducting a randomized, double-blind, placebo-controlled, cross-over study with a Latin square design ...